Table 3 Sociodemographic and clinical characteristics between the early response group and the early non-response group
Variable | Group A | Group B | t \({/F/\chi }^{2}\) | P |
|---|---|---|---|---|
Age—years | 28.22 ± 7.20 | 30.47 ± 7.27 | −1.86 | 0.065 |
Gender—(n, %) | 1.96 | 0.161 | ||
Female | 34, 48.57% | 46, 63.01% | ||
Male | 36, 51,43% | 27, 36.99% | ||
Onset age | 23.93 ± 6.44 | 24.88 ± 6.62 | −0.87 | 0.387 |
Course of disease | 2.73 ± 1.93 | 3.21 ± 1.63 | −1.60 | 0.112 |
Marital status—(n, %) | 4.77 | 0.092 | ||
Unmarried | 32, 45.71% | 31, 42.47% | ||
Married | 35, 50.00% | 31, 42.47% | ||
Divorced | 3, 4.29% | 11, 15.07% | ||
Living condition—(n, %) | 0.80 | 0.671 | ||
With spouse | 32, 45.71% | 30, 41.10% | ||
With parents | 36, 51.43% | 42, 57.53% | ||
Live alone | 2, 2.86% | 1, 1.37% | ||
Educational background—(n, %) | 1.78 | 0.879 | ||
Bachelor degree | 3, 4.29% | 4, 5.48% | ||
College degree | 3, 4.29% | 5, 6.85% | ||
Secondary specialized and high school | 18, 25.71% | 18, 24.66% | ||
Junior high school | 35, 50.00% | 34, 46.58% | ||
Primary school | 10, 14.29% | 12, 16.44% | ||
Illiteracy | 1, 1.43% | 0, 0.00% | ||
Family history | 0.11 | 0.736 | ||
Positive | 18, 25.71% | 17, 23.29% | ||
Negative | 52, 74.29% | 56, 76.71% | ||
Prescription drugs—(n, %) | 11.83 | 0.066 | ||
Aripiprazole | 10, 14.29% | 14, 19.18% | ||
Olanzapine | 20, 28.57% | 7, 9.59% | ||
Quetiapine | 9, 12.86% | 13, 17.81% | ||
Risperidone | 16, 22.86% | 12, 16.44% | ||
Ziprasidone | 7, 10.00% | 14, 19.18% | ||
Perphenazine | 3, 4.29% | 6, 8.22% | ||
Haloperidol | 5, 7.14% | 7, 9.59% |